Geode Capital Management’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.4K | Buy |
|
|||||
|
2025
Q4 | $50.1K | Buy |
|
|||||
|
2025
Q3 | $49K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $37.1K | Buy |
|
|||||
|
2024
Q4 | $38.9K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $21.2K | Hold |
|
|||||
|
2024
Q1 | $52.4K | Hold |
|
|||||
|
2023
Q4 | $48.2K | Buy |
|
|||||
|
2023
Q3 | $151K | Buy |
|
|||||
|
2023
Q2 | $287K | Hold |
|
|||||
|
2023
Q1 | $240K | Hold |
|
|||||
|
2022
Q4 | $318K | Buy |
|
|||||
|
2022
Q3 | $625K | Buy |
|
|||||
|
2022
Q2 | $35K | Hold |
|
|||||
|
2022
Q1 | $49K | Buy |
|
|||||
|
2021
Q4 | $56K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $389K | Buy |
|